Literature DB >> 33579941

AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.

Akanksha Bansal1, Matthias Schmidt1, Matthies Rennegarbe1, Christian Haupt1, Falk Liberta1, Sabrina Stecher1, Ioana Puscalau-Girtu1, Alexander Biedermann1, Marcus Fändrich2.   

Abstract

Systemic AA amyloidosis is a world-wide occurring protein misfolding disease of humans and animals. It arises from the formation of amyloid fibrils from serum amyloid A (SAA) protein. Using cryo electron microscopy we here show that amyloid fibrils which were purified from AA amyloidotic mice are structurally different from fibrils formed from recombinant SAA protein in vitro. Ex vivo amyloid fibrils consist of fibril proteins that contain more residues within their ordered parts and possess a higher β-sheet content than in vitro fibril proteins. They are also more resistant to proteolysis than their in vitro formed counterparts. These data suggest that pathogenic amyloid fibrils may originate from proteolytic selection, allowing specific fibril morphologies to proliferate and to cause damage to the surrounding tissue.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33579941      PMCID: PMC7881110          DOI: 10.1038/s41467-021-21129-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  48 in total

Review 1.  Pathology of animal amyloidoses.

Authors:  W Zschiesche; W Jakob
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

2.  Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.

Authors:  Joakim Bergström; Asa Gustavsson; Ulf Hellman; Knut Sletten; Charles L Murphy; Deborah T Weiss; Alan Solomon; Bert-Ove Olofsson; Per Westermark
Journal:  J Pathol       Date:  2005-06       Impact factor: 7.996

3.  MolProbity: More and better reference data for improved all-atom structure validation.

Authors:  Christopher J Williams; Jeffrey J Headd; Nigel W Moriarty; Michael G Prisant; Lizbeth L Videau; Lindsay N Deis; Vishal Verma; Daniel A Keedy; Bradley J Hintze; Vincent B Chen; Swati Jain; Steven M Lewis; W Bryan Arendall; Jack Snoeyink; Paul D Adams; Simon C Lovell; Jane S Richardson; David C Richardson
Journal:  Protein Sci       Date:  2017-11-27       Impact factor: 6.725

4.  Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils.

Authors:  Sara Raimondi; P Patrizia Mangione; Guglielmo Verona; Diana Canetti; Paola Nocerino; Loredana Marchese; Rebecca Piccarducci; Valentina Mondani; Giulia Faravelli; Graham W Taylor; Julian D Gillmore; Alessandra Corazza; Mark B Pepys; Sofia Giorgetti; Vittorio Bellotti
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

5.  Common Fibril Structures Imply Systemically Conserved Protein Misfolding Pathways In Vivo.

Authors:  Karthikeyan Annamalai; Falk Liberta; Marie-Theres Vielberg; William Close; Hauke Lilie; Karl-Heinz Gührs; Angelika Schierhorn; Rolf Koehler; Andreas Schmidt; Christian Haupt; Ute Hegenbart; Stefan Schönland; Matthias Schmidt; Michael Groll; Marcus Fändrich
Journal:  Angew Chem Int Ed Engl       Date:  2017-05-23       Impact factor: 15.336

6.  Polymorphism of Amyloid Fibrils In Vivo.

Authors:  Karthikeyan Annamalai; Karl-Heinz Gührs; Rolf Koehler; Matthias Schmidt; Henri Michel; Cornelia Loos; Patricia M Gaffney; Christina J Sigurdson; Ute Hegenbart; Stefan Schönland; Marcus Fändrich
Journal:  Angew Chem Int Ed Engl       Date:  2016-03-08       Impact factor: 15.336

7.  The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils.

Authors:  C Nordstedt; J Näslund; L O Tjernberg; A R Karlström; J Thyberg; L Terenius
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

8.  Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.

Authors:  Lynn Radamaker; Yin-Hsi Lin; Karthikeyan Annamalai; Stefanie Huhn; Ute Hegenbart; Stefan O Schönland; Günter Fritz; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2019-03-20       Impact factor: 14.919

9.  AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.

Authors:  Akanksha Bansal; Matthias Schmidt; Matthies Rennegarbe; Christian Haupt; Falk Liberta; Sabrina Stecher; Ioana Puscalau-Girtu; Alexander Biedermann; Marcus Fändrich
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

10.  Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis.

Authors:  Lynn Radamaker; Julian Baur; Stefanie Huhn; Christian Haupt; Ute Hegenbart; Stefan Schönland; Akanksha Bansal; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2021-02-08       Impact factor: 14.919

View more
  13 in total

Review 1.  General Principles Underpinning Amyloid Structure.

Authors:  Alexander I P Taylor; Rosemary A Staniforth
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

2.  Deterministic chaos in the self-assembly of β sheet nanotubes from an amphipathic oligopeptide.

Authors:  Fengbin Wang; Ordy Gnewou; Shengyuan Wang; Tomasz Osinski; Xiaobing Zuo; Edward H Egelman; Vincent P Conticello
Journal:  Matter       Date:  2021-07-27

Review 3.  Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis.

Authors:  Emily Lewkowicz; Olga Gursky
Journal:  Biophys Chem       Date:  2021-10-14       Impact factor: 3.628

4.  Structural Identification of Individual Helical Amyloid Filaments by Integration of Cryo-Electron Microscopy-Derived Maps in Comparative Morphometric Atomic Force Microscopy Image Analysis.

Authors:  Liisa Lutter; Youssra K Al-Hilaly; Christopher J Serpell; Mick F Tuite; Claude M Wischik; Louise C Serpell; Wei-Feng Xue
Journal:  J Mol Biol       Date:  2022-01-22       Impact factor: 5.469

5.  AA amyloid fibrils from diseased tissue are structurally different from in vitro formed SAA fibrils.

Authors:  Akanksha Bansal; Matthias Schmidt; Matthies Rennegarbe; Christian Haupt; Falk Liberta; Sabrina Stecher; Ioana Puscalau-Girtu; Alexander Biedermann; Marcus Fändrich
Journal:  Nat Commun       Date:  2021-02-12       Impact factor: 14.919

6.  Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer's Disease.

Authors:  Agnes Paulus; Anders Engdahl; Yiyi Yang; Antonio Boza-Serrano; Sara Bachiller; Laura Torres-Garcia; Alexander Svanbergsson; Megg G Garcia; Gunnar K Gouras; Jia-Yi Li; Tomas Deierborg; Oxana Klementieva
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

7.  Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM.

Authors:  Lynn Radamaker; Sara Karimi-Farsijani; Giada Andreotti; Julian Baur; Matthias Neumann; Sarah Schreiner; Natalie Berghaus; Raoul Motika; Christian Haupt; Paul Walther; Volker Schmidt; Stefanie Huhn; Ute Hegenbart; Stefan O Schönland; Sebastian Wiese; Clarissa Read; Matthias Schmidt; Marcus Fändrich
Journal:  Nat Commun       Date:  2021-11-05       Impact factor: 14.919

8.  Interconversion between Serum Amyloid A Native and Fibril Conformations.

Authors:  Fatih Yasar; Miranda S Sheridan; Ulrich H E Hansmann
Journal:  ACS Omega       Date:  2022-03-30

Review 9.  Structures of Pathological and Functional Amyloids and Prions, a Solid-State NMR Perspective.

Authors:  Asen Daskalov; Nadia El Mammeri; Alons Lends; Jayakrishna Shenoy; Gaelle Lamon; Yann Fichou; Ahmad Saad; Denis Martinez; Estelle Morvan; Melanie Berbon; Axelle Grélard; Brice Kauffmann; Mathias Ferber; Benjamin Bardiaux; Birgit Habenstein; Sven J Saupe; Antoine Loquet
Journal:  Front Mol Neurosci       Date:  2021-07-01       Impact factor: 5.639

10.  On the Dependence of Prion and Amyloid Structure on the Folding Environment.

Authors:  Irena Roterman; Katarzyna Stapor; Krzysztof Gądek; Tomasz Gubała; Piotr Nowakowski; Piotr Fabian; Leszek Konieczny
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.